Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LQDA
#3842
Liquidia Corporation - Common Stock
0.6
2
USD
-99.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-99.00%
Monthly Change
-98.38%
6 month change
-98.08%
Year Change
-97.26%
Previous Close
62.0
3
Open
0.6
2
Low
0.6
2
High
0.6
2
Volume
141
Markets
US Stock Market
Healthcare
LQDA
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
43.34 M
52.44 M
64.69 M
76.03 M
85.3 M
88.11 M
88.93 M
Valuation ratios
Enterprise value
73.74 M
208.28 M
320.55 M
812.8 M
826.63 M
2.85 B
5.2 B
Price to earnings ratio
-1.15
-6.96
-9.09
-9.53
-7.08
-43.11
358.82
Price to sales ratio
73.72
18.82
23.3
42.85
66.13
18.75
19.58
Price to cash flow ratio
-1.01
-7.11
-12.99
-18.03
-9.91
-83.17
131.54
Price to book ratio
0.77
3.71
4.11
15.85
11.98
66.33
30.1
Enterprise value to EBITDA ratio
-1.32
-7.4
-9.13
-11.42
-6.94
-57.14
110.38
Profitability ratios
Return on assets %
-0.6
-0.37
-0.32
-0.66
-0.57
-0.21
0.13
Return on equity %
-0.84
-0.53
-0.45
-1.66
-1.69
-1.54
0.49
Return on invested capital %
-641.93
-384.28
-471.63
-872.14
-943.32
-130.15
133.18
Gross margin %
73.74
76.48
82.06
83.49
58
99.68
100
Operating margin %
-7 989.03
-262.94
-243.3
-419.62
-866.63
-32.45
46.29
EBITDA margin %
-7 565.9
-219.28
-220.41
-407.17
-850.94
-31.49
46.66
Net margin %
-8 080.11
-269.02
-257.39
-448.89
-931.65
-43.53
39.79
Liquidity ratios
Quick ratio
—
—
—
—
4.42
1.84
2.03
Current ratio
5.63
8.36
11.34
4.85
4.43
2.01
2.22
Inventory turnover
—
—
—
—
24.39
0.02
—
Asset turnover
0.01
0.13
0.14
0.14
0.08
0.48
0.36
Solvency ratios
Debt to assets ratio
0.1
0.11
0.15
0.17
—
—
—
Debt to equity ratio
0.14
0.16
0.22
0.42
—
—
—
Long term debt to total assets ratio
—
—
0.15
—
—
—
—
Long term debt to total equity ratio
—
—
0.22
—
—
—
—
Per share metrics
Operating cash flow per share
-2.93
-0.69
-0.47
-0.64
-1.19
-0.41
0.46
EBIT per share
-3.2
-0.68
-0.64
-1.13
-1.54
-0.6
0.42
EBITDA per share
-3.03
-0.57
-0.58
-1.1
-1.51
-0.58
0.44
Total debt per share
0.61
0.21
0.33
0.31
—
—
—
Cash per share
3.53
1.16
1.53
1.29
2.24
2.22
2.2
Net current asset value per share
3.57
1.23
1.64
1.38
2.35
3.18
3.29
Tangible book value per share
3.85
1.31
1.48
0.73
0.98
0.44
1.01
Working capital per share
2.94
1.09
1.49
1.1
1.82
1.6
1.81
Book value per share
3.85
1.31
1.48
0.73
0.98
0.52
1.07
News
FDA Grants Priority Review to SNY's Filing for Gaucher Disease Drug
Are You Looking for a Top Momentum Pick? Why Liquidia Corporation (LQDA) is a Great Choice
TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study
CORT to Resubmit NDA for Relacorilant in Cushing's Syndrome, Stock Up
AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication
Dyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD Therapy
Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?
AGIO's Pyrukynd Gets Approval for Thalassemia in Europe
GILD Scores FDA Win for HDV Drug, CHMP Backs Trodelvy
CHMP Backs EU Approval of Novo Nordisk's Wegovy Pill for Obesity
BDTX Stock Slumps on Mixed Phase II Frontline NSCLC Study Data
Here's Why You Should Add Altimmune Stock to Your Portfolio Now